MG
CPIX icon

Marex Group’s Cumberland Pharmaceuticals CPIX Stock Holding History

Marex Group’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118K Buy
+36,423
New +$140K ﹤0.01% 940

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Marex Group's CPIX Position: Q1 2026 in Review

Marex Group opened a new position in Cumberland Pharmaceuticals (CPIX) in Q1 2026: 36,423 shares worth $118K. The stake represents ﹤0.01% of the portfolio and ranks #940 among its holdings.

29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Marex Group held 36,423 shares of Cumberland Pharmaceuticals worth $118K as of Q1 2026.
  • Cumberland Pharmaceuticals was a new Marex Group position in Q1 2026.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #940 holding.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.